Valérie Molinier-Frenkel

Associate Professor (MCU-PH)

Assistance Publique - Hôpitaux de Paris

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Valérie Molinier-Frenkel is an Associate Professor at Assistance Publique - Hôpitaux de Paris in France. Her research focuses on neuropathies, cardiac amyloidosis, and the implications of immunoglobulin A monoclonal gammopathy. Recent articles authored by her examine the prevalence of neuropathies, prognostic factors in cardiac amyloidosis, and innovations in diagnostic algorithms and quality of life assessments for affected patients.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Florence Niedergang

CNRS Délégation Paris-Villejuif

FRANCE

View details

FREDERIC FIORE

Head of Genetic Engineering Department, PhD

INSERM Délégation régionale Provence Alpes Cote d'Azur et Corse

FRANCE

View details

Armelle Prevost-Blondel

INSERM

FRANCE

View details

Flavia Castellano

Université Paris-Saclay

FRANCE

View details

Bruno LUCAS

CNRS Délégation Paris B

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Valérie Molinier-Frenkel

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy

Upregulation of IL4‐induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties

Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study

Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patients.

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis.

Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France

Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis.

IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike

Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis.

Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy.

Prevalence and determinants of iron deficiency in cardiac amyloidosis.

Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival.

Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.

Collaborators (5)

Florence Niedergang

FREDERIC FIORE

Armelle Prevost-Blondel

Flavia Castellano

Bruno LUCAS

Make your next move.